The Patent Finder

Atherogenics, Inc.

Also on record
Records under this name other than patents Atherogenics, Inc. holds now: patents now held by others, patents whose terms have ended, and its applications, pending or abandoned.

Back to Atherogenics, Inc.

PatentTitleStatus Expires Confidence
US 6,121,319Monoesters of probucol for the treatment of cardiovascular and inflammatory disease
Formerly held
Term ended
Term ended May 14, 2018 · From the USPTO record
Term endedTerm ended May 14, 2018From the USPTO record
US 6,147,250Compounds and methods for the inhibition of the expression of VCAM-1
Formerly held
Term ended
Term ended May 14, 2018 · From the USPTO record
Term endedTerm ended May 14, 2018From the USPTO record
US 8,252,840Methods of derivatives of probucol for the treatment of type II diabetes
Formerly held
Lapsed on the fee record
Ended Aug 28, 2016 · From the USPTO record
Lapsed on the fee recordEnded Aug 28, 2016From the USPTO record
US 7,294,737Process of preparing esters and ethers of probucol and derivatives thereof
Formerly held
Lapsed on the fee record
Ended Nov 13, 2015 · From the USPTO record
Lapsed on the fee recordEnded Nov 13, 2015From the USPTO record
US 7,273,948Process of preparing esters and ethers of probucol and derivatives thereof
Formerly held
Lapsed on the fee record
Ended Sep 25, 2015 · From the USPTO record
Lapsed on the fee recordEnded Sep 25, 2015From the USPTO record
US 7,271,274Phenolic antioxidants for the treatment of disorders including arthritis, asthma and coronary artery disease
Formerly held
Lapsed on the fee record
Ended Sep 18, 2015 · From the USPTO record
Lapsed on the fee recordEnded Sep 18, 2015From the USPTO record
US 6,617,352Compounds and methods for the inhibition of the expression of VCAM-1
Formerly held
Lapsed on the fee record
Ended Sep 9, 2015 · From the USPTO record
Lapsed on the fee recordEnded Sep 9, 2015From the USPTO record
US 6,602,914Compounds and methods for the inhibition of the expression of VCAM-1
Formerly held
Lapsed on the fee record
Ended Aug 5, 2015 · From the USPTO record
Lapsed on the fee recordEnded Aug 5, 2015From the USPTO record
US 7,247,714Protection against oxidative stress and inflammation by a cytoprotective response element
Formerly held
Lapsed on the fee record
Ended Jul 24, 2015 · From the USPTO record
Lapsed on the fee recordEnded Jul 24, 2015From the USPTO record
US 6,548,699Compounds and methods for the inhibition of the expression of VCAM-1
Formerly held
Lapsed on the fee record
Ended Apr 15, 2015 · From the USPTO record
Lapsed on the fee recordEnded Apr 15, 2015From the USPTO record
10 of 32 patents shown.
Pro members see all 32.
Pro members: see all 32 patents
The Patent Finder CompaniesExpirationsCalculatorWatchlistPricing MethodologyCorrectionsLegalPrivacysupport@thepatentfinder.com Updated Nov 16, 2026 · includes USPTO assignment & status data published Nov 16, 2026 and grant & fee data published Nov 10, 2026 (weekly) Part of 137 Finder · © 2026 137 Finder LLC · Sources cited